Anticoagulation is not mandatory after stenting for malignant superior vena cava syndrome

Affiliations

Comment

Frédéric Thony et al. Cardiovasc Intervent Radiol. 2014 Oct.

. 2014 Oct;37(5):1403-4.

doi: 10.1007/s00270-014-0902-5. Epub 2014 May 8.

¹ Clinique Universitaire de Radiologie et Imagerie Médicale, Chu Grenoble BP 217, 38043, Grenoble Cedex 09, France, FThony@chu-grenoble.fr.

No abstract available

Comment on

Endovascular treatment of malignant superior vena cava syndrome: results and predictive factors of clinical efficacy.
Fagedet D, Thony F, Timsit JF, Rodiere M, Monnin-Bares V, Ferretti GR, Vesin A, Moro-Sibilot D. Fagedet D, et al. Cardiovasc Intervent Radiol. 2013 Feb;36(1):140-9. doi: 10.1007/s00270-011-0310-z. Epub 2011 Dec 7. Cardiovasc Intervent Radiol. 2013. PMID: 22146975
Anticoagulant therapy in oncologic patients undergoing venous stenting for superior vena cava syndrome and other interventional procedures.
Iaccarino V, Venetucci P, Brunetti A, Ramundo V, Di Minno G. Iaccarino V, et al. Cardiovasc Intervent Radiol. 2014 Oct;37(5):1401-2. doi: 10.1007/s00270-013-0791-z. Epub 2014 Jan 25. Cardiovasc Intervent Radiol. 2014. PMID: 24464255 No abstract available.